Published online Jul 21, 2023. doi: 10.3748/wjg.v29.i27.4344
Peer-review started: March 29, 2023
First decision: May 23, 2023
Revised: June 6, 2023
Accepted: July 6, 2023
Article in press: July 6, 2023
Published online: July 21, 2023
Processing time: 105 Days and 20.9 Hours
The presence of right-sided ligamentum teres (RSLT) is often accompanied by portal venous anomalies (PVAs) and is considered a worrisome characteristic in hepatobiliary interventions. Most studies hypothesis that left-sided gallbladder (LGB) must exist with RSLT. However, in a reported study, right-sided gallbladder (RGB) was observed in livers with RSLT. Therefore, the relationship between the ligamentum teres hepatis (LT), gallbladder (GB), and PVAs is controversial and requires further investigation, despite the rarity of the anatomical variation of LT and GB, which can complicate statistical analysis.
To verify whether the RSLT coexists with a typical RGB, represent genuine existing variations or were merely misinterpreted and to determine the key predictors of major PVA, we conducted a comprehensive investigation. Additionally, to the best of our knowledge, all previous articles focusing on the RSLT had small sample sizes, not exceeding 1000.
First, to draw attention to the uncommon occurrence of the RSLT without the presence of the gallbladder (LGB), and secondly, to assess the reliability of both the LT and gallbladder location in predicting PVAs.
This retrospective study examined a total of 8552 contrast-enhanced abdominal computed tomography examinations conducted between 2018 and 2021, involving 4483 men and 4069 women, with a mean age of 59.5 ± 16.2 (SD) years. The primary focus was to assess major PVAs as a surrogate outcome. The cases were categorized into four subgroups based on the locations of the gallbladder and LT. On one hand, we analyzed the prevalence of PVAs based on LT locations while controlling for gallbladder location (n = 36). On the other hand, we controlled for LT location and determined the prevalence of PVAs based on gallbladder locations (n = 34). Lastly, we investigated the independent influence of LT location on PVA using propensity score matching (PSM) and inverse probability of treatment weighting (IPTW).
We identified a total of 9 cases where the RSLT coexisted with a typical RGB location. Among the cases with a LGB, the presence of RSLT was associated with a significantly higher prevalence of PVAs compared to those with a typical LT [80.0% vs 18.2%, P = 0.001; odds ratio (OR) = 18, 95% confidence interval (CI): 2.92-110.96]. However, when RSLT was present, there was no statistically significant difference in PVA prevalence between RGB and LGB cases (88.9% vs 80.0%, P > 0.99). We employed PSM and IPTW to ensure balanced cohorts in terms of demographics and gallbladder locations. After adjusting for these factors using PSM, the RSLT group still exhibited a significantly higher PVAs prevalence compared to the LT group (77.3% vs 4.5%, P < 0.001; OR = 16.27, 95%CI: 2.25-117.53). Similar results were observed when utilizing IPTW (82.5% vs 4.7%, P < 0.001).
RSLT doesn't always coexist with LGB. RSLT can predict PVA independently while the gallbladder location does not serve as a sufficient predictor.
Further investigation is needed to determine whether the existence of RSLT can predict the most predominant type of biliary or arterial anatomical variation.